1. Abatacept in IgG4-related disease: a prospective, open-label, single-arm, single-centre, proof-of-concept study. (February 2022) Authors: Matza, Mark A; Perugino, Cory A; Harvey, Liam; Fernandes, Ana D; Wallace, Zachary S; Liu, Hang; Allard-Chamard, Hugues; Pillai, Shiv; Stone, John H Journal: Lancet Issue: Volume 4:Number 2(2022) Page Start: e105 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗